Intracameral epinephrine without the addition of intracameral lidocaine in the management of tamsulosin associated intraoperative floppy iris syndrome

Clin Ter. 2015;166(4):158-61. doi: 10.7417/CT.2015.1862.

Abstract

Objective: Intracameral mydriatics using epinephrine associated with lidocaine have been reported as efficacious in reducing intraoperative floppy iris syndrome (IFIS) complications during cataract surgery. The aim of this study was to verify the efficacy of intracameral epinephrine without intracameral lidocaine as prophylaxis against IFIS in patients on tamsulosin.

Materials and methods: This was a retrospective study on the results of cataract surgery in 18 patients on therapy with tamsulosin. Patients had undergone routine phacoemulsification in one eye. Successively, they underwent phacoemulsifcation in the fellow eye using non preserved intracameral epinephrine 1:4000 diluted with BSS. Intraoperative complications during cataract surgery had been documented and IFIS was graded based on iris billowing, miosis or iris prolapse. Follow-up was 3 months.

Results: Thirty-six eyes of 18 patients were included in the evaluation. The incidence of IFIS was significantly higher in the eyes where routine phacoemulsificaton had been performed (100%) with respect to eyes where phacoemulsification was carried out using intracameral epinephrine (33%) (Chi Square test =15.12, p<0.001). In routine phacoemulsification 16 eyes showed iris billowing, 14 eyes had some extent of miosis and 14 eyes had tendency to iris prolapse. In phacoemulsification with the use of intracameral epinephrine 5 eyes showed iris billowing, 4 eyes presented some extent of miosis and 2 eyes had tendency to iris prolapse. There were no serious intraoperative complications.

Conclusions: Intracameral epinephrine without the addition of lidocaine was efficacious in the management of IFIS in patients on tamsulosin.

Keywords: Intracameral lidocaine; Intraoperative floppy iris syndrome, intracameral epinephrine; Tamsulosin; α1-adrenergic receptor antagonists.

Publication types

  • Evaluation Study

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists / adverse effects*
  • Aged
  • Epinephrine / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Intraoperative Complications / chemically induced
  • Intraoperative Complications / prevention & control*
  • Iris Diseases / chemically induced
  • Iris Diseases / prevention & control*
  • Lidocaine / therapeutic use*
  • Male
  • Mydriatics / therapeutic use*
  • Phacoemulsification
  • Retrospective Studies
  • Sulfonamides / adverse effects*
  • Syndrome
  • Tamsulosin
  • Treatment Outcome

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Mydriatics
  • Sulfonamides
  • Lidocaine
  • Tamsulosin
  • Epinephrine